CellCentric vs ONCOMATRYX
CellCentric vs ONCOMATRYX, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and ONCOMATRYX on 50/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 50/100
- domain rating: 35/100 against 26/100
- headcount: 53 against 36
- funding raised: $375M against $107M
- LinkedIn following: 28,695 against 5,170
ONCOMATRYX
- agent readiness: 36/100 against 32/100
At a glance
| Measure | CellCentric | ONCOMATRYX |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2003 | 2009 |
| Headquarters | Cambridge, United Kingdom | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | CellCentric | ONCOMATRYX |
|---|---|---|
| Employees | 53 | 36 |
| Total funding | $375M | $107M |
| Latest round | Series D | Funding Round |
| LinkedIn followers | 28,695 | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 50/100 |
| Traction | 57/100 | 56/100 |
| Team | 60/100 | 30/100 |
| Search visibility | 44/100 | 37/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | ONCOMATRYX |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
CellCentric vs ONCOMATRYX: common questions
Which is better, CellCentric or ONCOMATRYX?
On our 0-100 score CellCentric rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do CellCentric and ONCOMATRYX compare on the numbers?
CellCentric leads on our overall score (60/100 against 50/100), domain rating (35/100 against 26/100), headcount (53 against 36), funding raised ($375M against $107M), LinkedIn following (28,695 against 5,170). ONCOMATRYX leads on agent readiness (36/100 against 32/100).
Read the full CellCentric review and pricing or the ONCOMATRYX review and pricing. You can also browse other CellCentric alternatives we track.